X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7626) 7626
Newspaper Article (672) 672
Publication (540) 540
Book Review (228) 228
Newsletter (155) 155
Book Chapter (137) 137
Book / eBook (94) 94
Magazine Article (61) 61
Transcript (50) 50
Dissertation (35) 35
Trade Publication Article (31) 31
Report (13) 13
Conference Proceeding (9) 9
Government Document (8) 8
Web Resource (7) 7
Reference (6) 6
Data Set (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4551) 4551
parkinson's disease (3917) 3917
index medicus (3321) 3321
male (2869) 2869
animals (2278) 2278
female (2240) 2240
parkinsons disease (2076) 2076
parkinsons-disease (1863) 1863
neurosciences (1852) 1852
clinical neurology (1692) 1692
middle aged (1622) 1622
aged (1579) 1579
parkinson disease - drug therapy (1314) 1314
dopamine (1292) 1292
parkinson disease, secondary - chemically induced (1279) 1279
neurodegenerative diseases (1148) 1148
movement disorders (1137) 1137
research (1126) 1126
adult (938) 938
rats (905) 905
care and treatment (894) 894
parkinson disease, secondary - drug therapy (830) 830
neurons (799) 799
neurology (796) 796
pharmacology & pharmacy (773) 773
medicine (770) 770
brain (758) 758
psychiatry (754) 754
mice (734) 734
nervous system (713) 713
disease models, animal (705) 705
neurodegeneration (690) 690
oxidative stress (678) 678
research article (656) 656
health aspects (649) 649
antiparkinson agents - therapeutic use (638) 638
levodopa - therapeutic use (630) 630
studies (626) 626
proteins (607) 607
parkinson disease (603) 603
rodents (584) 584
drug therapy (582) 582
medical research (581) 581
parkinson disease - physiopathology (581) 581
analysis (578) 578
multidisciplinary sciences (574) 574
dementia (567) 567
alzheimers-disease (565) 565
patients (539) 539
risk factors (537) 537
parkinson’s disease (528) 528
levodopa (523) 523
parkinson disease - complications (522) 522
treatment outcome (514) 514
science (506) 506
clinical trials (494) 494
disease (493) 493
apoptosis (478) 478
neuroprotection (468) 468
diagnosis (462) 462
alzheimers disease (452) 452
nervous system diseases (443) 443
aged, 80 and over (438) 438
basal ganglia (434) 434
quality of life (432) 432
dopamine - metabolism (430) 430
neuroscience (429) 429
alzheimer's disease (421) 421
physiological aspects (415) 415
medicine, experimental (413) 413
double-blind (412) 412
surgery (410) 410
review (406) 406
parkinson disease - metabolism (404) 404
rats, sprague-dawley (397) 397
brain research (396) 396
parkinson disease - therapy (385) 385
dopamine receptors (384) 384
inflammation (384) 384
alpha-synuclein (374) 374
biochemistry & molecular biology (365) 365
antipsychotic agents - adverse effects (355) 355
biology (353) 353
substantia-nigra (351) 351
gene expression (331) 331
article (330) 330
usage (322) 322
dose-response relationship, drug (320) 320
parkinson disease - pathology (319) 319
cell biology (317) 317
levodopa - adverse effects (314) 314
drug dosages (313) 313
medicine, research & experimental (311) 311
parkinsonism (308) 308
time factors (303) 303
neurotoxicity (302) 302
neurons - metabolism (297) 297
development and progression (293) 293
antiparkinson agents - adverse effects (292) 292
substantia nigra (292) 292
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Providence Healthcare - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Baycrest Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Missing (1) 1
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Music - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8542) 8542
German (91) 91
French (62) 62
Spanish (53) 53
Russian (42) 42
Japanese (22) 22
Italian (16) 16
Portuguese (13) 13
Chinese (10) 10
Polish (10) 10
Dutch (8) 8
Swedish (5) 5
Romanian (4) 4
Czech (3) 3
Danish (3) 3
Turkish (3) 3
Norwegian (2) 2
Arabic (1) 1
Finnish (1) 1
Hungarian (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 02/2017, Volume 127, Issue 2, pp. 720 - 734
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3355 - 3370
Axonal degeneration is one of the earliest features of Parkinson's disease pathology, which is followed by neuronal death in the substantia nigra and other... 
axonal degeneration | Parkinson's disease | rho kinase | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | dopaminergic cell death | CONTROLLED-TRIAL | SIGNALING PATHWAYS | REGENERATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | CELL-DEATH | COENZYME Q | IN-VITRO | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | NEURITE OUTGROWTH | DOUBLE-BLIND | Neuroprotective Agents - therapeutic use | Rats, Wistar | Dopaminergic Neurons - pathology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Male | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Neuroprotective Agents - metabolism | rho-Associated Kinases - antagonists & inhibitors | Parkinson Disease, Secondary - pathology | Neuroprotective Agents - pharmacology | Parkinson Disease, Secondary - drug therapy | Dopaminergic Neurons - physiology | Behavior, Animal - drug effects | Parkinson Disease, Secondary - chemically induced | Proto-Oncogene Proteins c-akt - metabolism | Cell Survival - physiology | Dopamine - metabolism | Disease Models, Animal | Substantia Nigra - enzymology | Cell Survival - drug effects | rho-Associated Kinases - physiology | Nerve Degeneration - enzymology | Mice, Inbred C57BL | Cells, Cultured | Axons - drug effects | Rats | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use | Behavior, Animal - physiology | MPTP Poisoning - drug therapy | MPTP Poisoning - enzymology | Parkinson Disease, Secondary - enzymology | Neurites - pathology | Dopaminergic Neurons - enzymology | Substantia Nigra - drug effects | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Axons - pathology | 1-Methyl-4-phenylpyridinium - toxicity | Mice | Nerve Degeneration - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Cell culture | Neuroprotection | Animal models | Cell survival | Dopamine | Neurodegenerative diseases | Substantia nigra | Central nervous system | AKT protein | Motor task performance | Rho-associated kinase | Axons | Regeneration | Metabolites | Neurodegeneration | Neostriatum | Axon guidance | Movement disorders
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2011, Volume 286, Issue 18, pp. 16504 - 16515
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, p. 7495
Journal Article
Journal Article
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 07/2009, Volume 29, Issue 30, pp. 9651 - 9659
Journal Article
Journal Article
Journal Article